Professional Documents
Culture Documents
Drugdesigndiscoveryanddevelopmentnew 160517115015 PDF
Drugdesigndiscoveryanddevelopmentnew 160517115015 PDF
What is really meant by drug design is ligand design (i.e., design of a small
molecule that will bind tightly to its target). Although modeling techniques for
prediction of binding affinity are reasonably successful, there are many
other properties, such as bioavailability, metabolic half-life, lack of side
effects, etc., that first must be optimized before a ligand can become a safe
and efficacious drug.
The ‘drug design’ in a broader sense implies random
evaluation of synthetic as well as natural products in
bioassay systems, creation of newer drug molecules
based on biologically-active-prototypes derived from
either plant or animal kingdom (lead compound),
synthesis of congeners displaying interesting biological
actions by different approaches of molecular
modifications and finally precise design of a drug to
enable it to interact with a receptor site efficaciously.
Drug design frequently but not necessarily relies on
computer modeling techniques. This type of modeling is
often referred to as computer-aided drug design.
Finally, drug design that relies on the knowledge of the
three-dimensional structure of the biomolecular target is
known as structure-based drug design.
Drug Discovery: It is an effort to produce new drug
molecules from a lead compound by applying variety
of approaches of design. Drug design approach is
the prerequisite for drug discovery.
Choose a disease
Choose a drug target
Identify a bioassay
Find a ‘lead compound’
Isolate and purify the lead compound if necessary
Determine the structure of the lead compound
Identify structure-activity relationships (SARs)
Identify the pharmacophore
Improve target interactions
Drug Development
Example:
i. Sulphanilamide- isolated from the degradation of prontosil or
synthesized chemically and acts as antibacterial agent.
ii. Lead compound from natural sources: Morphine from opium,
cocaine from coca leaves, and quinine from the bark of
cinchona tree.
Objective / Aim of drug design strategy
Lead generation:
Natural ligand / Screening
Biological Testing
Structure Analysis
Biological Testing
and Compound Design
If promising
Database searching
Manual
metabolism of drug
pharmacokinetics
Molecular modification of lead compound:
Formation of Analogues and Prodrugs
OH O OH O O
OH
1 NH2
8 6 5
7 OH
H3C OHH H N(CH3)2
Tetracycline
Activity: against wide range of gram-positive and gram-negative bacteria
including rickettsia, Mycoplasma etc.
OH O OH O O
OH O OH O O OH
OH
NH2
NH2
OH
OH
Cl H OH N(CH3)2
ClH3C OH N(CH3)2
Chortetracycline Demeclocycline
OH O OH O O
OH
NH2
OH
H3C OHOH N(CH3)2
Oxytetracycline
The term prodrug is applied to either an appropriate
derivative of a drug that undergoes in vivo
hydrolysis of the parent drug, e.g., testosterone
propionate, chloramphenicol palmitate and the like;
or an analogue which is metabolically transformed
to a biologically active drug, for instance:
phenylbutazone undergoes in vivo hydroxylation to
oxyphenylbutazone.
O
N
N
n-C4H9
OH
O
Oxyphenylbutazone
N
n-C4H9
O
Phenylbutazone N
HO O
Phenylbutazone alcohol
(uricosuric agent)
Serendipitous drug discovery
"Serendipity" in drug discovery implies the finding of one
thing while looking for something else i.e. accidental
discovery or discovery by chance.
(4) (1)
H2N SO2NH2
Sulphanilamide: first synthesized by Gelmo in 1908 as an intermediate in the study of azo dyes.
Therapeutic value was ascertained by Gerhard Domagk (German scientist) in 1935. Found active
against streptococci.
NH2
H2N SO2NH2 NaNO2/HCl
ClN N SO2NH2 H2N NH2
10 0C
Sulphanilamide
Diazotized sulphanilamide P-aminophenyldiamine
NH2
Reduction
H2N SO2NH2 H2N N N SO2NH2
N
H2N SO2NH
N H2N SO2NH
N
Sulphpyridine: more potent than
sulphanilamide for the treatment Sulphadiazine: dysentery, pneumonia.
of pneumonia but more toxic.
CH3
S
H2N SO2NH H2N SO2NH O
N N
Sulphathiazole: very effective in Sulfamethoxazole: UTI, RTI, GI infections.
staphylococcal infections.
Serendipitous Discovery of Chlordiazepoxide (Librium)
without a Lead
R1 N R1
N
O X N+ -
X O
N
Y R2
Y R2
2.5
2. 4
2. 6
CH3NH2
NHCH3. HCl
NHCH3 N
N CH2NHCH3 N
N+ - . .CH2 Cl Cl N+
O N O-
Cl Cl
OH